查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1930097

注射生理食鹽水市場規模、佔有率、成長及全球產業分析：按類型、應用和地區劃分的洞察，2026-2034 年

Normal Saline for Parenteral Use Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2026-2034
出版日期: | 出版商: Fortune Business Insights Pvt. Ltd. | 英文 118 Pages | 商品交期: 請詢問到貨日

價格

注射生理食鹽水市場成長驅動因子

全球注射生理食鹽水市場正經歷穩定成長，這主要得益於醫院對輸液的需求不斷增加，這些輸液用於治療脫水、電解質失衡、敗血症、出血和傷口護理等疾病。根據 Fortune Business Insights 預測，2025 年該市場規模預計將達到 39.1 億美元，2026 年增長至 41.7 億美元，並最終在 2034 年達到 71.5 億美元。這意味著 2026 年至 2034 年的複合年增長率 (CAGR) 為 6.97%。預計到 2025 年，北美將以 39.46% 的市佔率引領市場，這主要歸功於 0.9% 氯化鈉溶液的高普及率以及主要廠商在擴大產能方面的策略投資。 生理食鹽水（0.9% 氯化鈉溶液）是最常用的晶體溶液之一，並被 "倖存敗血症運動" (SSC) 推薦用於敗血症休剋期間的液體復甦。全球新生兒敗血症發生率的不斷上升（每年每 1000 例活產嬰兒中診斷出 1-50 例）進一步推動了對生理食鹽水的需求。住院人數上升、人口老化以及政府指南建議在重症監護中使用生理食鹽水也是促成因素。

新冠疫情的影響

由於擇期手術延遲和住院人數減少，新冠疫情暫時對市場成長造成了負面影響。在疫情高峰期，全球超過2,800萬例擇期手術被取消，ICU Med等機構報告稱，2020年上半年靜脈輸液收入下降了10.3%。儘管面臨這些不利因素，但由於疫情後的復甦和對醫療基礎設施的日益重視，市場正在恢復成長。

市場趨勢

流感季期間，尤其是H3N2等嚴重病毒株流行時，對生理食鹽水的需求激增。例如，歐盟每年報告的流感感染病例高達 5,000 萬例，促使住院人數增加，生理食鹽水的使用量也隨之上升。同樣，美國在 2018-2019 年流感季期間的住院人數為 490,561 人。這些趨勢凸顯了生理食鹽水在病人補液和藥物輸注方面發揮的關鍵作用。

市場成長因素

1. 重症監護領域使用量增加：生理食鹽水對於治療脫水、嘔吐和腹瀉，以及在加護病房 (ICU) 和新生兒加護病房 (NICU) 進行液體療法至關重要。美國每年售出約 2 億公升生理食鹽水，全球每天使用量超過 100 萬公升。

2.住院和手術數量增加：住院和手術數量的增加進一步推動了需求，因為靜脈輸液是醫院護理的標準組成部分。例如，英國國家醫療服務體系 (NHS) 報告稱，每年有超過 500 萬例急性住院病例，其中許多病例需要靜脈輸註生理食鹽水。

3. 政府指南：歐洲重症醫學會 (ESICM) 等機構的建議支持在重症監護中廣泛使用生理鹽水，從而推動了市場滲透。

限制因子

由於轉向使用平衡電解質輸液，市場正面臨挑戰。研究表明，與生理食鹽水相比，平衡電解質輸液可降低死亡率和腎損傷，從而影響醫院的採用。例如，范德比爾特大學的一項研究表明，每 100 名接受平衡電解質輸液的患者中，死亡或嚴重腎臟併發症的發生率降低 1 例。

市場區隔

按類型

  • 塑膠瓶：由於其不易破損且易於分銷，預計到 2026 年將成為領先細分市場，佔 89.33% 的市場佔有率。
  • 玻璃瓶：由於其污染風險低且具有環保優勢，玻璃瓶預計將保持穩定成長。

按應用

  • 靜脈輸液：佔最大的市佔率（截至 2026 年為 97.45%）。這是因為靜脈輸液是最常用的給藥途徑。
  • 肌肉注射：由於其給藥方便且創傷小，預計肌肉注射將保持穩定增長。

依地區劃分

  • 北美：最大的市場，預計2025年將達到15.4億美元，2026年將達到16.5億美元。美國預計2026年將達15.7億美元。
  • 亞太地區：由於住院人數增加、老年人口增長以及敗血症盛行率上升，預計將顯著增長。預計到2026年，日本將達到7億美元，中國和印度將分別達到8,000萬美元。
  • 歐洲：在政府支持和鼓勵的推動下，預計到2026年，英國將達到8,000萬美元，德國將達到1.1億美元。
  • 世界其他地區：由於醫療基礎設施的改善，預計拉丁美洲以及中東和非洲將實現溫和成長。

主要參與者

推動市場發展的主要參與者包括百特（美國）、科倫集團（中國）、貝朗醫療（德國）、費森尤斯卡比（德國）和ICU Medical（美國）。這些公司專注於研發、策略合作和產能擴張。例如，2022年8月，Assure Infusions宣佈在佛羅裡達州建造一座全自動靜脈輸液工廠，以滿足美國市場的高需求。

目錄

第一章：引言

第二章：摘要整理

第三章：市場動態

  • 市場驅動因素
  • 市場限制因素
  • 市場機遇

第四章：關鍵考慮因素

  • 主要國家及地區住院病患人數（2025年）
  • 主要國家和地區主要疾病盛行率（2025年）
  • 關鍵產業趨勢－併購與合作
  • 新冠疫情對市場的影響

第五章：全球靜脈輸液市場分析、洞察與預測 2021-2034

  • 市場分析、洞察與預測 - 按類型劃分
    • 塑膠瓶
    • 玻璃瓶
  • 市場分析、洞察與預測 - 按應用劃分
    • 肌肉注射
    • 靜脈注射
  • 市場分析、洞察與預測 - 按地區劃分
    • 北美
    • 歐洲
    • 亞太地區
    • 拉丁美洲
    • 中東和非洲

第六章：北美注射生理食鹽水市場分析、洞察與預測（2021-2034）

  • 依國家劃分
    • 美國各州
    • 加拿大

第7章 歐洲的注射用生理食鹽水市場分析，洞察與預測，2021～2034年

第8章 亞太地區的注射用生理食鹽水市場分析，洞察與預測，2021～2034年

第9章 南美的注射用生理食鹽水市場分析，洞察與預測(2021～2034年)

第10章 中東·非洲的注射用生理食鹽水市場分析，洞察與預測，2021～2034年

第11章 競爭分析

  • 全球市場佔有率分析(2025年)
  • 企業簡介
    • Baxter
    • Kelun Group
    • B. Braun Melsungen AG
    • Fresenius Kabi AG
    • SSY Group Limited
    • ICU Medical
    • Double-Crane Pharmaceutical Co., Ltd.
    • Otsuka Pharmaceutical Co., Ltd.
    • Cisen Pharmaceutical Co., Ltd.
    • Pharmally International Holding Co., Ltd.
    • 其他的主要企業
Product Code: FBI104520

Growth Factors of normal saline for parenteral use Market

The global normal saline for parenteral use market is witnessing steady growth, driven by the increasing demand for intravenous fluids in hospitals for conditions such as dehydration, electrolyte imbalance, sepsis, hemorrhage, and wound dressing. According to Fortune Business Insights, the market was valued at USD 3.91 billion in 2025 and is projected to grow to USD 4.17 billion in 2026, ultimately reaching USD 7.15 billion by 2034, reflecting a CAGR of 6.97% during 2026-2034. North America dominated the market in 2025 with a 39.46% share, largely due to the high uptake of 0.9% sodium chloride solutions and strategic investments by key players to expand production capacity.

Normal saline (0.9% sodium chloride) is one of the most commonly used crystalloid fluids, particularly recommended by the Surviving Sepsis Campaign (SSC) for fluid resuscitation in septic shock. The rising incidence of neonatal sepsis globally-diagnosed in 1 to 50 per 1,000 live births annually-further boosts demand for normal saline. Increasing hospital admissions, geriatric populations, and government guidelines recommending saline in critical care are additional growth drivers.

COVID-19 Impact

The COVID-19 pandemic had a temporary negative impact on market growth due to postponed elective surgeries and reduced hospital admissions. Over 28 million elective surgeries were canceled globally during the peak disruption, and organizations like ICU Med reported a 10.3% revenue decrease for IV solutions in the first half of 2020. Despite this setback, post-pandemic recovery and an increased focus on healthcare infrastructure have allowed the market to resume its growth trajectory.

Market Trends

Demand for normal saline spikes during flu seasons, particularly with severe strains such as H3N2. For example, the European Union reported up to 50 million influenza infections annually, driving hospitalizations and saline use. Similarly, the U.S. experienced 490,561 hospital admissions during the 2018-2019 flu season. These trends highlight the critical role of normal saline in patient hydration and medication delivery.

Market Growth Factors

1. Rising Use in Critical Care: Saline is essential for managing dehydration, vomiting, diarrhea, and fluid resuscitation in ICU and NICU settings. Approximately 200 million liters of saline are sold annually in the U.S., while over 1 million liters are administered globally each day.

2. Hospital Admissions and Surgeries: Growing numbers of in-patients and surgical procedures further fuel demand, as intravenous therapy is a standard component of hospital care. For instance, the NHS reports over 5 million acute hospital admissions annually, many requiring IV saline.

3. Government Guidelines: Recommendations from bodies such as the European Society of Intensive Care Medicine (ESICM) support the widespread use of saline in critical care, strengthening market adoption.

Restraining Factors

The market faces challenges due to the shift toward balanced IV fluids. Studies indicate that balanced solutions reduce mortality and kidney damage compared to normal saline, influencing hospital adoption. For example, a Vanderbilt University study found one fewer death or severe kidney complication per 100 patients administered balanced fluids.

Market Segmentation

By Type:

  • Plastic Bottles: Dominant segment, expected to hold 89.33% of the market in 2026, due to breakage prevention and easier distribution.
  • Glass Bottles: Offers lower contamination risk and environmental benefits; projected to grow steadily.

By Application:

  • Intravenous Injection: Largest share (97.45% in 2026) due to being the preferred administration route.
  • Intramuscular Injection: Expected to grow steadily due to ease of administration and low invasiveness.

By Region:

  • North America: Largest market, USD 1.54 billion in 2025, rising to USD 1.65 billion in 2026, with the U.S. projected at USD 1.57 billion in 2026.
  • Asia Pacific: Significant growth due to rising hospital admissions, geriatric population, and sepsis prevalence; Japan at USD 0.7 billion, China and India at USD 0.08 billion each in 2026.
  • Europe: Driven by government support and recommendations; UK at USD 0.08 billion, Germany at USD 0.11 billion in 2026.
  • Rest of the World: Moderate growth in Latin America and Middle East & Africa due to improving healthcare infrastructure.

Key Players

Major companies shaping the market include Baxter (U.S.), Kelun Group (China), B. Braun Melsungen AG (Germany), Fresenius Kabi AG (Germany), ICU Medical (U.S.), among others. These firms focus on R&D, strategic collaborations, and production capacity expansion. For example, in August 2022, Assure Infusions announced a fully automated IV fluids plant in Florida to meet high U.S. demand.

Conclusion

The global normal saline for parenteral use market is set for consistent growth, expanding from USD 3.91 billion in 2025 to USD 7.15 billion by 2034, driven by increasing hospitalizations, surgical procedures, sepsis incidence, and supportive government guidelines. Despite challenges from the shift to balanced fluids, innovations in packaging, distribution, and production capacity, along with rising demand across North America, Europe, and Asia Pacific, are expected to sustain market growth and ensure the widespread availability of saline for critical care applications globally.

Segmentation By Type

  • Plastic Bottles
  • Glass Bottles

By Application

  • Intramuscular injection
  • Intravenous injection

By Geography

  • North America (By Type, Application, and Country)
    • U.S.
    • Canada
  • Europe (By Type, Application, and Country)
    • Germany
    • France
    • U.K.
    • Italy
    • Russia
    • Rest of Europe
  • Asia Pacific (By Type, Application, and Country)
    • China
    • Japan
    • South Korea
    • India
    • Australia
    • Taiwan
    • Indonesia
    • Thailand
    • Malaysia
    • Rest of the Asia Pacific
  • Latin America (By Type, Application, and Country)
    • Mexico
    • Brazil
    • Colombia
    • Argentina
    • Rest of Latin America
  • Middle East & Africa (By Type, Application, and Country)
    • Turkey
    • Saudi Arabia
    • UAE
  • Rest of the Middle East & Africa

Table of Content

1. Introduction

  • 1.1. Research Scope
  • 1.2. Market Segmentation
  • 1.3. Research Methodology
  • 1.4. Definitions and Assumptions

2. Executive Summary

3. Market Dynamics

  • 3.1. Market Drivers
  • 3.2. Market Restraints
  • 3.3. Market Opportunities

4. Key Insights

  • 4.1. Number of Hospital Admissions, By Key Countries/Regions, 2025
  • 4.2. Prevalence of Key Diseases, By Key Countries/Regions, 2025
  • 4.3. Key Industry Developments - Mergers, Acquisitions, and Partnerships
  • 4.4. Impact of COVID-19 on the Market

5. Global Normal Saline for Parenteral Use Market Analysis, Insights and Forecast, 2021-2034

  • 5.1. Market Analysis, Insights and Forecast - By Type
    • 5.1.1. Plastic Bottles
    • 5.1.2. Glass Bottles
  • 5.2. Market Analysis, Insights and Forecast - By Application
    • 5.2.1. Intramuscular Injection
    • 5.2.2. Intravenous Injection
  • 5.3. Market Analysis, Insights and Forecast - By Region
    • 5.3.1. North America
    • 5.3.2. Europe
    • 5.3.3. Asia Pacific
    • 5.3.4. Latin America
    • 5.3.5. Middle East & Africa

6. North America Normal Saline for Parenteral Use Market Analysis, Insights and Forecast, 2021-2034

  • 6.1. Market Analysis, Insights and Forecast - By Type
    • 6.1.1. Plastic Bottles
    • 6.1.2. Glass Bottles
  • 6.2. Market Analysis, Insights and Forecast - By Application
    • 6.2.1. Intramuscular Injection
    • 6.2.2. Intravenous Injection
  • 6.3. Market Analysis, Insights and Forecast - By Country
    • 6.3.1. U.S.
    • 6.3.2. Canada

7. Europe Normal Saline for Parenteral Use Market Analysis, Insights and Forecast, 2021-2034

  • 7.1. Market Analysis, Insights and Forecast - By Type
    • 7.1.1. Plastic Bottles
    • 7.1.2. Glass Bottles
  • 7.2. Market Analysis, Insights and Forecast - By Application
    • 7.2.1. Intramuscular Injection
    • 7.2.2. Intravenous Injection
  • 7.3. Market Analysis, Insights and Forecast - By Countries/ Sub-region
    • 7.3.1. U.K.
    • 7.3.2. Germany
    • 7.3.3. France
    • 7.3.4. Spain
    • 7.3.5. Russia
    • 7.3.6. Rest of Europe

8. Asia Pacific Normal Saline for Parenteral Use Market Analysis, Insights and Forecast, 2021-2034

  • 8.1. Market Analysis, Insights and Forecast - By Type
    • 8.1.1. Plastic Bottles
    • 8.1.2. Glass Bottles
  • 8.2. Market Analysis, Insights and Forecast - By Application
    • 8.2.1. Intramuscular Injection
    • 8.2.2. Intravenous Injection
  • 8.3. Market Analysis, Insights and Forecast - By Countries/ Sub-region
    • 8.3.1. Japan
    • 8.3.2. China
    • 8.3.3. India
    • 8.3.4. Australia
    • 8.3.5. South Korea
    • 8.3.6. Taiwan
    • 8.3.7. Indonesia
    • 8.3.8. Thailand
    • 8.3.9. Malaysia
    • 8.3.10. Rest of Asia Pacific

9. Latin America Normal Saline for Parenteral Use Market Analysis, Insights and Forecast, 2021-2034

  • 9.1. Market Analysis, Insights and Forecast - By Type
    • 9.1.1. Plastic Bottles
    • 9.1.2. Glass Bottles
  • 9.2. Market Analysis, Insights and Forecast - By Application
    • 9.2.1. Intramuscular Injection
    • 9.2.2. Intravenous Injection
  • 9.3. Market Analysis, Insights and Forecast - By Countries/ Sub regions
    • 9.3.1. Brazil
    • 9.3.2. Mexico
    • 9.3.3. Colombia
    • 9.3.4. Argentina
    • 9.3.5. Rest of Latin America

10. Middle East & Africa Normal Saline for Parenteral Use Market Analysis, Insights and Forecast, 2021-2034

  • 10.1. Market Analysis, Insights and Forecast - By Type
    • 10.1.1. Plastic Bottles
    • 10.1.2. Glass Bottles
  • 10.2. Market Analysis, Insights and Forecast - By Application
    • 10.2.1. Intramuscular Injection
    • 10.2.2. Intravenous Injection
  • 10.3. Market Analysis, Insights and Forecast - By Countries/ Sub region
    • 10.3.1. Turkey
    • 10.3.2. Saudi Arabia
    • 10.3.3. UAE
    • 10.3.4. Rest of Middle East & Africa

11. Competitive Analysis

  • 11.1. Global Market Share Analysis (2025)
  • 11.2. Company Profiles
    • 11.2.1. Baxter
      • 11.2.1.1. Overview
      • 11.2.1.2. Product
      • 11.2.1.3. SWOT analysis
      • 11.2.1.4. Recent developments
      • 11.2.1.5. strategies
      • 11.2.1.6. financials (based on availability)
    • 11.2.2. Kelun Group
      • 11.2.2.1. Overview
      • 11.2.2.2. Product
      • 11.2.2.3. SWOT analysis
      • 11.2.2.4. Recent developments
      • 11.2.2.5. strategies
      • 11.2.2.6. financials (based on availability)
    • 11.2.3. B. Braun Melsungen AG
      • 11.2.3.1. Overview
      • 11.2.3.2. Product
      • 11.2.3.3. SWOT analysis
      • 11.2.3.4. Recent developments
      • 11.2.3.5. strategies
      • 11.2.3.6. financials (based on availability)
    • 11.2.4. Fresenius Kabi AG
      • 11.2.4.1. Overview
      • 11.2.4.2. Product
      • 11.2.4.3. SWOT analysis
      • 11.2.4.4. Recent developments
      • 11.2.4.5. strategies
      • 11.2.4.6. financials (based on availability)
    • 11.2.5. SSY Group Limited
      • 11.2.5.1. Overview
      • 11.2.5.2. Product
      • 11.2.5.3. SWOT analysis
      • 11.2.5.4. Recent developments
      • 11.2.5.5. strategies
      • 11.2.5.6. financials (based on availability)
    • 11.2.6. ICU Medical
      • 11.2.6.1. Overview
      • 11.2.6.2. Product
      • 11.2.6.3. SWOT analysis
      • 11.2.6.4. Recent developments
      • 11.2.6.5. strategies
      • 11.2.6.6. financials (based on availability)
    • 11.2.7. Double-Crane Pharmaceutical Co., Ltd.
      • 11.2.7.1. Overview
      • 11.2.7.2. Product
      • 11.2.7.3. SWOT analysis
      • 11.2.7.4. Recent developments
      • 11.2.7.5. strategies
      • 11.2.7.6. financials (based on availability)
    • 11.2.8. Otsuka Pharmaceutical Co., Ltd.
      • 11.2.8.1. Overview
      • 11.2.8.2. Product
      • 11.2.8.3. SWOT analysis
      • 11.2.8.4. Recent developments
      • 11.2.8.5. strategies
      • 11.2.8.6. financials (based on availability)
    • 11.2.9. Cisen Pharmaceutical Co., Ltd.
      • 11.2.9.1. Overview
      • 11.2.9.2. Product
      • 11.2.9.3. SWOT analysis
      • 11.2.9.4. Recent developments
      • 11.2.9.5. strategies
      • 11.2.9.6. financials (based on availability)
    • 11.2.10. Pharmally International Holding Co., Ltd.
      • 11.2.10.1. Overview
      • 11.2.10.2. Product
      • 11.2.10.3. SWOT analysis
      • 11.2.10.4. Recent developments
      • 11.2.10.5. strategies
      • 11.2.10.6. financials (based on availability)
    • 11.2.11. Other Prominent Players

List of Tables

  • Table 01: Global Normal Saline for Parenteral Use Market Revenue (USD billion) Forecast, by Type, 2021-2034
  • Table 02: Global Normal Saline for Parenteral Use Market Volume (million liters) Forecast, by Type, 2021-2034
  • Table 03: Global Normal Saline for Parenteral Use Market Revenue (USD billion) Forecast, by Application, 2021-2034
  • Table 04: Global Normal Saline for Parenteral Use Market Volume (million liters) Forecast, by Application, 2021-2034
  • Table 05: Global Normal Saline for Parenteral Use Market Revenue (USD billion) Forecast, by Region, 2021-2034
  • Table 06: Global Normal Saline for Parenteral Use Market Volume (million liters) Forecast, by Region, 2021-2034
  • Table 07: North America Normal Saline for Parenteral Use Market Revenue (USD billion) Forecast, by Type, 2021-2034
  • Table 08: North America Normal Saline for Parenteral Use Market Volume (million liters) Forecast, by Type, 2021-2034
  • Table 09: North America Normal Saline for Parenteral Use Market Revenue (USD billion) Forecast, by Application, 2021-2034
  • Table 10: North America Normal Saline for Parenteral Use Market Volume (million liters) Forecast, by Application, 2021-2034
  • Table 11: North America Normal Saline for Parenteral Use Market Revenue (USD billion) Forecast, by Country, 2021-2034
  • Table 12: North America Normal Saline for Parenteral Use Market Volume (million liters) Forecast, by Country, 2021-2034
  • Table 13: Europe Normal Saline for Parenteral Use Market Revenue (USD billion) Forecast, by Type, 2021-2034
  • Table 14: Europe Normal Saline for Parenteral Use Market Volume (million liters) Forecast, by Type, 2021-2034
  • Table 15: Europe Normal Saline for Parenteral Use Market Revenue (USD billion) Forecast, by Application, 2021-2034
  • Table 16: Europe Normal Saline for Parenteral Use Market Volume (million liters) Forecast, by Application, 2021-2034
  • Table 17: Europe Normal Saline for Parenteral Use Market Revenue (USD billion) Forecast, by Country/Sub-region, 2021-2034
  • Table 18: Europe Normal Saline for Parenteral Use Market Volume (million liters) Forecast, by Country/Sub-region, 2021-2034
  • Table 19: Asia Pacific Normal Saline for Parenteral Use Market Revenue (USD billion) Forecast, by Type, 2021-2034
  • Table 20: Asia Pacific Normal Saline for Parenteral Use Market Volume (million liters) Forecast, by Type, 2021-2034
  • Table 21: Asia Pacific Normal Saline for Parenteral Use Market Revenue (USD billion) Forecast, by Application, 2021-2034
  • Table 22: Asia Pacific Normal Saline for Parenteral Use Market Volume (million liters) Forecast, by Application, 2021-2034
  • Table 23: Asia Pacific Normal Saline for Parenteral Use Market Revenue (USD billion) Forecast, by Country/Sub-region, 2021-2034
  • Table 24: Asia Pacific Normal Saline for Parenteral Use Market Volume (million liters) Forecast, by Country/Sub-region, 2021-2034
  • Table 25: Latin America Normal Saline for Parenteral Use Market Revenue (USD billion) Forecast, by Type, 2021-2034
  • Table 26: Latin America Normal Saline for Parenteral Use Market Volume (million liters) Forecast, by Type, 2021-2034
  • Table 27: Latin America Normal Saline for Parenteral Use Market Revenue (USD billion) Forecast, by Application, 2021-2034
  • Table 28: Latin America Normal Saline for Parenteral Use Market Volume (million liters) Forecast, by Application, 2021-2034
  • Table 29: Latin America Normal Saline for Parenteral Use Market Revenue (USD million) Forecast, by Country/Sub-region, 2021-2034
  • Table 30: Latin America Normal Saline for Parenteral Use Market Volume (million liters) Forecast, by Country/Sub-region, 2021-2034
  • Table 31: Middle East & Africa Normal Saline for Parenteral Use Market Revenue (USD billion) Forecast, by Type, 2021-2034
  • Table 32: Middle East & Africa Normal Saline for Parenteral Use Market Volume (million liters) Forecast, by Type, 2021-2034
  • Table 33: Middle East & Africa Normal Saline for Parenteral Use Market Revenue (USD billion) Forecast, by Application, 2021-2034
  • Table 34: Middle East & Africa Normal Saline for Parenteral Use Market Volume (million liters) Forecast, by Application, 2021-2034
  • Table 35: Middle East & Africa Normal Saline for Parenteral Use Market Revenue (USD billion) Forecast, by Country/Sub-region, 2021-2034
  • Table 36: Middle East & Africa Normal Saline for Parenteral Use Market Volume (million liters) Forecast, by Country/Sub-region, 2021-2034

List of Figures

  • Figure 01: Global Normal Saline for Parenteral Use Market Revenue Breakdown (USD Billion, %) by Region, 2025 & 2034
  • Figure 02: Global Normal Saline for Parenteral Use Market Value Share (%), by Type, 2025 & 2034
  • Figure 03: Global Normal Saline for Parenteral Use Market Value Share (%), by Application, 2025 & 2034
  • Figure 04: Global Normal Saline for Parenteral Use Market Value Share (%), by Region, 2025 & 2034
  • Figure 05: North America Normal Saline for Parenteral Use Market Value (USD Billion), by Type, 2025 & 2034
  • Figure 06: North America Normal Saline for Parenteral Use Market Value Share (%), by Type, 2025
  • Figure 07: North America Normal Saline for Parenteral Use Market Value (USD Billion), by Application, 2025 & 2034
  • Figure 08: North America Normal Saline for Parenteral Use Market Value Share (%), by Application, 2025
  • Figure 09: North America Normal Saline for Parenteral Use Market Value (USD Billion), by Country, 2025 & 2034
  • Figure 10: North America Normal Saline for Parenteral Use Market Value Share (%), by Country, 2025
  • Figure 11: Europe Normal Saline for Parenteral Use Market Value (USD Billion), by Type, 2025 & 2034
  • Figure 12: Europe Normal Saline for Parenteral Use Market Value Share (%), by Type, 2025
  • Figure 13: Europe Normal Saline for Parenteral Use Market Value (USD Billion), by Application, 2025 & 2034
  • Figure 14: Europe Normal Saline for Parenteral Use Market Value Share (%), by Application, 2025
  • Figure 15: Europe Normal Saline for Parenteral Use Market Value (USD Billion), by Country/Sub-region, 2025 & 2034
  • Figure 16: Europe Normal Saline for Parenteral Use Market Value Share (%), by Country/Sub-region, 2025
  • Figure 17: Asia Pacific Normal Saline for Parenteral Use Market Value (USD Billion), by Type, 2025 & 2034
  • Figure 18: Asia Pacific Normal Saline for Parenteral Use Market Value Share (%), by Type, 2025
  • Figure 19: Asia Pacific Normal Saline for Parenteral Use Market Value (USD Billion), by Application, 2025 & 2034
  • Figure 20: Asia Pacific Normal Saline for Parenteral Use Market Value Share (%), by Application, 2025
  • Figure 21: Asia Pacific Normal Saline for Parenteral Use Market Value (USD Billion), by Country/Sub-region, 2025 & 2034
  • Figure 22: Asia Pacific Normal Saline for Parenteral Use Market Value Share (%), by Country/Sub-region, 2025
  • Figure 23: Latin America Normal Saline for Parenteral Use Market Value (USD Billion), by Type, 2025 & 2034
  • Figure 24: Latin America Normal Saline for Parenteral Use Market Value Share (%), by Type, 2025
  • Figure 25: Latin America Normal Saline for Parenteral Use Market Value (USD Billion), by Application, 2025 & 2034
  • Figure 26: Latin America Normal Saline for Parenteral Use Market Value Share (%), by Application, 2025
  • Figure 27: Latin America Normal Saline for Parenteral Use Market Value Share (%), by Type, 2025 & 2034
  • Figure 28: Latin America Normal Saline for Parenteral Use Market Value Share (%), by Application, 2025 & 2034
  • Figure 29: Latin America Normal Saline for Parenteral Use Market Value (USD Billion), by Country/Sub-region, 2025 & 2034
  • Figure 30: Latin America Normal Saline for Parenteral Use Market Value Share (%), by Country/Sub-region, 2025
  • Figure 31: Middle East & Africa Normal Saline for Parenteral Use Market Value (USD Billion), by Type, 2025 & 2034
  • Figure 32: Middle East & Africa Normal Saline for Parenteral Use Market Value Share (%), by Type, 2025
  • Figure 33: Middle East & Africa Normal Saline for Parenteral Use Market Value (USD Billion), by Application, 2025 & 2034
  • Figure 34: Middle East & Africa Normal Saline for Parenteral Use Market Value Share (%), by Application, 2025
  • Figure 35: Middle East & Africa Normal Saline for Parenteral Use Market Value (USD Billion), by Country/Sub-region, 2025 & 2034
  • Figure 36: Middle East & Africa Normal Saline for Parenteral Use Market Value Share (%), by Country/Sub-region, 2025
  • Figure 37: Global Normal Saline for Parenteral Use Market Share Analysis (%), By Company, 2025